CAS: 932372-01-5

2-(5-(4-((4-Isopropoxyphenyl)Sulfonyl)Piperazin-1-Yl)-2-(Oxazol-2-Yl)Phenoxy)Acetic Acid

Asapiprant (S-555739) is a potent and selective DP1 receptor antagonist (Ki: 0.44 nM). It exhibited high affinity and selectivity for the DP1 receptor.

Asapiprant

Asapiprant is a metabolic product of the drug asacol. It has been shown to have anti-inflammatory effects and has been used in studies to determine its efficacy in treating humans infected with covid-19 pandemic. Asapiprant has also been shown to be an effective diagnostic agent for detecting the presence of eicosanoids in nasal fluid. This compound has not yet been tested on animals or humans.